Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?

od Al-Kassmy, Jawad, Pedersen, Jannie, Kobinger, Gary
izdano v Viruses (2020)

Inflammatory pathways of importance for management of inflammatory bowel disease

od Pedersen, Jannie, Coskun, Mehmet, Soendergaard, Christoffer, Salem, Mohammad, Nielsen, Ole Haagen
Izdano 2014

Cell Culture Studies of the Efficacy and Barrier to Resistance of Sofosbuvir-Velpatasvir and Glecaprevir-Pibrentasvir against Hepatitis C Virus Genotypes 2a, 2b, and 2c

od Ramirez, Santseharay, Fernandez-Antunez, Carlota, Mikkelsen, Lotte S., Pedersen, Jannie, Li, Yi-Ping, Bukh, Jens
izdano v Antimicrob Agents Chemother (2020)

Neutralizing Antibodies in Patients with Chronic Hepatitis C, Genotype 1, against a Panel of Genotype 1 Culture Viruses: Lack of Correlation to Treatment Outcome

od Pedersen, Jannie, Jensen, Tanja B., Carlsen, Thomas H. R., Schønning, Kristian, Christensen, Peer Brehm, Laursen, Alex Lund, Krarup, Henrik, Bukh, Jens, Weis, Nina
Izdano 2013

Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a

od Carlsen, Thomas H.R., Pedersen, Jannie, Prentoe, Jannick C., Giang, Erick, Keck, Zhen-Yong, Mikkelsen, Lotte S., Law, Mansun, Foung, Steven K. H., Bukh, Jens
izdano v Hepatology (2014)

Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies

od Pedersen, Jannie, Carlsen, Thomas H. R., Prentoe, Jannick, Ramirez, Santseharay, Jensen, Tanja B., Forns, Xavier, Alter, Harvey, Foung, Steven K. H., Law, Mansun, Gottwein, Judith, Weis, Nina, Bukh, Jens
izdano v Hepatology (2013)